EverQuote (EVER)
(Delayed Data from NSDQ)
$22.74 USD
+0.83 (3.79%)
Updated Jul 9, 2024 04:00 PM ET
After-Market: $22.73 -0.01 (-0.04%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$22.74 USD
+0.83 (3.79%)
Updated Jul 9, 2024 04:00 PM ET
After-Market: $22.73 -0.01 (-0.04%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth C Momentum B VGM
Zacks News
Reasons Why EverQuote (EVER) Stock is an Attractive Pick
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from inorganic growth, solid performance of automotive insurance providers and financial flexibility.
Progressive (PGR) to Release Q3 Earnings: Is a Beat in Store?
by Zacks Equity Research
Progressive's (PGR) Q3 earnings are likely to reflect improved rates, solid policies in force and higher retention in its strong Vehicle and Property businesses.
EverQuote (EVER) Down 11.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
EverQuote (EVER) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should You Retain EverQuote (EVER) Stock in Your Portfolio?
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from inorganic growth, growth in commissions revenue and financial flexibility.
Allstate (ALL) Q2 Earnings Beat on Higher Premiums, Costs Ail
by Zacks Equity Research
Allstate (ALL) has $1.8 billion left under its share buyback authorization.
MetLife (MET) Q2 Earnings Beat on Strong Latin America Unit
by Zacks Equity Research
MetLife's (MET) adjusted net investment income declines on reduced variable investment income, stemming from decreased private equity returns.
Can EverQuote (EVER) Climb 42% to Reach the Level Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at a 42.4% upside potential for EverQuote (EVER). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
EverQuote (EVER) Q2 Loss Narrower Than Expected, View Tweaked
by Zacks Equity Research
EverQuote's (EVER) Q2 results witnessed lower revenues from Automotive insurance but higher revenues in the Other insurance vertical. Expenses decreased.
EverQuote (EVER) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
EverQuote (EVER) delivered earnings and revenue surprises of 74.47% and 7.15%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Reasons Why Investors Should Retain EverQuote (EVER) Stock Now
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from higher quote requests, the solid performance of automotive insurance providers and financial flexibility.
Should You Retain EverQuote (EVER) Stock in Your Portfolio?
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from higher quote requests, solid performance of automotive insurance providers and sufficient liquidity.
Why Is EverQuote (EVER) Down 26.4% Since Last Earnings Report?
by Zacks Equity Research
EverQuote (EVER) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Prudential (PRU) Q1 Earnings Beat, Fall Y/Y, Dividend Up (Revised)
by Zacks Equity Research
Prudential's (PRU) Q1 results reflect higher contributions from U.S. Businesses, partially offset by poor performance of PGIM and International businesses.
Assurant (AIZ) Q1 Earnings Beat Estimates, Increase Y/Y (Revised)
by Zacks Equity Research
Assurant's (AIZ) Q1 results reflect higher net investment income and lower catastrophes losses, offset by higher expenses.
Prudential (PRU) Q1 Earnings Beat, Fall Y/Y, Dividend Up
by Zacks Equity Research
Prudential's (PRU) Q1 results reflect higher contributions from U.S. Businesses, partially offset by poor performance of PGIM and International businesses.
Assurant (AIZ) Q1 Earnings Beat Estimates, Increase Y/Y
by Zacks Equity Research
Assurant's (AIZ) Q1 results reflect higher net investment income and lower catastrophes losses, offset by higher expenses.
EverQuote (EVER) Q1 Loss Lower Than Expected, Revenues Up Y/Y
by Zacks Equity Research
EverQuote's (EVER) 1Q results reflect higher revenues from Automotive insurance and Other insurance verticals in the reported quarter, partially offset by higher expenses.
EverQuote (EVER) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
EverQuote (EVER) delivered earnings and revenue surprises of 26.92% and 8.76%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Community West Bancshares (CWBC) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Community West Bancshares (CWBC) delivered earnings and revenue surprises of 28.57% and 1.92%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for EverQuote (EVER) This Earnings Season?
by Zacks Equity Research
EverQuote (EVER) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
EverQuote (EVER) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
EverQuote (EVER) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
EverQuote (EVER) Down 8.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
EverQuote (EVER) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Hold EverQuote (EVER) in Your Portfolio
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from strategic acquisitions, improved guidance and sufficient liquidity.
EverQuote (EVER) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
EverQuote's (EVER) Q4 results reflect growth in the Variable Marketing Margin and a solid performance in the other insurance vertical.
EverQuote (EVER) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
EverQuote (EVER) delivered earnings and revenue surprises of 9.38% and 5.90%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?